Academic literature on the topic 'Min jian hu zhu hui'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Min jian hu zhu hui.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Min jian hu zhu hui"

1

Xiao, Xiao, Rui Qi, Hui-Ju Han, et al. "Molecular identification and phylogenetic analysis of Cryptosporidium, Hepatozoon and Spirometra in snakes from central China." International Journal for Parasitology: Parasites and Wildlife 10 (December 31, 2019): 274–80. https://doi.org/10.1016/j.ijppaw.2019.10.001.

Full text
Abstract:
Xiao, Xiao, Qi, Rui, Han, Hui-Ju, Liu, Jian-Wei, Qin, Xiang-Rong, Fang, Li-Zhu, Zhou, Chuan-Min, Gong, Xiao-Qing, Lei, Si-Cong, Yu, Xue-Jie (2019): Molecular identification and phylogenetic analysis of Cryptosporidium, Hepatozoon and Spirometra in snakes from central China. International Journal for Parasitology: Parasites and Wildlife 10: 274-280, DOI: 10.1016/j.ijppaw.2019.10.001, URL: http://dx.doi.org/10.1016/j.ijppaw.2019.10.001
APA, Harvard, Vancouver, ISO, and other styles
2

Cheng, Ying, Jie Wang, Caicun Zhou, et al. "Abstract CT038: Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage SCLC: A phase 3 trial." Cancer Research 82, no. 12_Supplement (2022): CT038. http://dx.doi.org/10.1158/1538-7445.am2022-ct038.

Full text
Abstract:
Abstract Introduction: Extensive-stage small cell lung cancer (ES-SCLC) is associated with limited treatment options and poor prognosis. Immunotherapy has recently showed robust clinical activity in ES-SCLC. In this double-blind, phase 3 trial, we evaluated adebrelimab (SHR-1316), a novel anti-PD-L1 antibody, in combination with standard chemotherapy (chemo) as first-line treatment for ES-SCLC. Methods: Patients naïve to systemic treatment for ES-SCLC were randomized 1:1 to receive 4-6 cycles of adebrelimab (20 mg/kg, iv, d1, q3w) or placebo with carboplatin (AUC 5, d1, q3w) plus etoposide (10
APA, Harvard, Vancouver, ISO, and other styles
3

Li, Dan, Yu-Yan Jiang, Zhi-Min Jin та ін. "Isolation and absolute configurations of diastereomers of 8 -hydroxy-T-muurolol and (1 ,6β,7β)-cadinane-4-en-8 ,10 -diol from Chimonanthus salicifolius". Phytochemistry 122 (29 лютого 2016): 294–300. https://doi.org/10.1016/j.phytochem.2016.01.005.

Full text
Abstract:
Li, Dan, Jiang, Yu-Yan, Jin, Zhi-Min, Li, Hai-Yan, Xie, Hu-Jun, Wu, Bin, Wang, Kui-Wu (2016): Isolation and absolute configurations of diastereomers of 8 -hydroxy-T-muurolol and (1 ,6β,7β)-cadinane-4-en-8 ,10 -diol from Chimonanthus salicifolius. Phytochemistry 122: 294-300, DOI: 10.1016/j.phytochem.2016.01.005, URL: http://dx.doi.org/10.1016/j.phytochem.2016.01.005
APA, Harvard, Vancouver, ISO, and other styles
4

Liu, Hao−Lan, Tengfei Zhu, Xinyi Wen, et al. "Chemical and Microbial Differences of Root and Rhizosphere Soil among Different Provenances of Fokienia hodginsii." Forests 15, no. 6 (2024): 1005. http://dx.doi.org/10.3390/f15061005.

Full text
Abstract:
Aims: Fokienia hodginsii is a threatened conifer tree species, known as the dominant nursery-grown species capable of colonizing the challenging woodland environments in southern China due to its strong root penetrating ability. The ecological phenotype of Fokienia hodginsii is not well documented during its breeding process, which limits the potential planting area and its ecological function. This study aims to understand how Fokienia hodginsii associates with microbes to conduct its key ecological function and provide a theoretical basis for further improving the forest nursery management o
APA, Harvard, Vancouver, ISO, and other styles
5

Cheng, Ying, Xiqin Zhang, Lin Wu, et al. "Abstract CT126: Aumolertinib as adjuvant therapy in patients with stage II-IIIB EGFR-mutated NSCLC after complete tumor resection: A randomized, double-blind, placebo-controlled, phase 3 trial (ARTS)." Cancer Research 85, no. 8_Supplement_2 (2025): CT126. https://doi.org/10.1158/1538-7445.am2025-ct126.

Full text
Abstract:
Abstract Background: Lung cancer is the primary cause of cancer-related morbidity and mortality globally. Approximately 30% of patients with EGFR mutation (EGFRm) in NSCLC are diagnosed at an early stage and are candidates for curative-intent surgical resection; however, disease recurrence remains a substantial clinical challenge. Aumolertinib is a third-generation EGFR TKI that potently inhibits both sensitizing EGFR mutations (ex19del/L858R) and the resistance mutation T790M. ARTS (NCT04687241) is a randomized, double-blind, placebo-controlled, multicenter, phase 3 trial designed to evaluate
APA, Harvard, Vancouver, ISO, and other styles
6

LEE, Won-seok. "Two Interpretations of Spring and Autumn Annals[春秋] in the Mid-Joseon Period". Tae Dong Institute of classic research 48 (30 червня 2022): 37–66. http://dx.doi.org/10.31408/tdicr.2022.48.37.

Full text
Abstract:
This article attempted to investigate the pluralistic aspects of the interpretation of Spring and Autumn[『春秋』] in the middle of the Joseon Dynasty, focusing on A Detailed Commentary on Spring and Autumn Annals[春秋瑣說] of Shin Min-il (申敏一) and the criticism of it by Jo Ik(趙翼). Duke Yin[隱公]’s enthronement and death were significant events that caused various controversies regarding the core principles of patriarchal clan system[宗法制] during the Spring and Autumn period, so it was subject to intensive review by later researchers. Regarding Duke Yin’s behavior, Gongyang Commentary On Spring And Autum
APA, Harvard, Vancouver, ISO, and other styles
7

Yu, Peng, Teng Huang, Senlin Hu, and Xuefeng Yu. "Predictive value of relative fat mass algorithm for incident hypertension: a 6-year prospective study in Chinese population." BMJ Open 10, no. 10 (2020): e038420. http://dx.doi.org/10.1136/bmjopen-2020-038420.

Full text
Abstract:
ObjectivesIndividuals with obesity especially excessive visceral adiposity have high risk for incident hypertension. Recently, a new algorithm named relative fat mass (RFM) was introduced to define obesity. Our aim was to investigate whether it can predict hypertension in Chinese population and to compare its predictive power with traditional indices including body mass index (BMI), waist circumference (WC) and waist-to-height ratio (WHtR).DesignA 6-year prospective study.SettingNine provinces (Hei Long Jiang, Liao Ning, Jiang Su, Shan Dong, He Nan, Hu Bei, Hu Nan, Guang Xi and Gui Zhou) in Ch
APA, Harvard, Vancouver, ISO, and other styles
8

Zhang, Jian, Dongmei Ji, Li Cai, et al. "Abstract P2-13-10: First-in-human HER2-targeted bispecific antibody KN026 for the treatment of patients with HER2-positive metastatic breast cancer: Results from a phase I study." Cancer Research 82, no. 4_Supplement (2022): P2–13–10—P2–13–10. http://dx.doi.org/10.1158/1538-7445.sabcs21-p2-13-10.

Full text
Abstract:
Abstract PURPOSE KN026 is a novel bispecific antibody that simultaneously binds to two distinct HER2 epitopes. This firstinhuman Phase I study evaluated the safety/tolerability, pharmacokinetics (PK), preliminary efficacy, and potential predictive biomarker activity of KN026 administered as monotherapy to HER2-positive metastatic breast cancer (MBC) patients. METHODS Female patients with HER2 positive MBC who failed prior antiHER2 therapies received intravenous KN026 monotherapy at 5 mg/kg (QW), 10 mg/kg (QW), 20 mg/kg (Q2W), or 30 mg/kg (Q3W). Dose escalation was guided by a “3+3” doseescalat
APA, Harvard, Vancouver, ISO, and other styles
9

Li, Ziming, Xiaomin Dang, Dingzhi Huang, et al. "Abstract CT246: Open-label, single-arm, multicenter, phase 2 trial of garsorasib in KRAS G12C-mutated non-small-cell lung cancer." Cancer Research 84, no. 7_Supplement (2024): CT246. http://dx.doi.org/10.1158/1538-7445.am2024-ct246.

Full text
Abstract:
Abstract Background: Garsorasib (D-1553), a potent KRAS G12C inhibitor, has previously demonstrated promising anti-tumor activity in KRAS G12C-mutated non-small-cell lung cancer (NSCLC) in a phase 1 study. Here we present the efficacy and safety of garsorasib in a pivotal phase 2 study. Methods: In this open-label, multicenter, single-arm phase 2 study, patients received garsorasib 600 mg twice daily in 21-day cycles. Eligible criteria included patients with locally advanced or metastatic NSCLC harboring KRAS G12C mutation, who had disease progression after prior anti-PD-(L)1 therapy and plati
APA, Harvard, Vancouver, ISO, and other styles
10

Chen, Kai, Xiaolin Chen, Shunrong Li, et al. "Abstract PO1-22-08: Ductal Lavage versus Oral Corticosteroids in Patients with Idiopathic Granulomatous Mastitis: A Multicenter, Open-label, Randomized, Controlled, Non-inferiority Study." Cancer Research 84, no. 9_Supplement (2024): PO1–22–08—PO1–22–08. http://dx.doi.org/10.1158/1538-7445.sabcs23-po1-22-08.

Full text
Abstract:
Abstract Background: Idiopathic granulomatous mastitis (IGM) is an inflammatory breast disease characterized by the presence of mass, erythema and fistula. Various treatments have been proposed, including steroids, surgery, immunosuppressants, and observation alone. However, most of the reported studies are single-center, retrospective, single-arm with limited sample sizes, leaving the optimal treatment strategy unknown. In a previous single-arm study, we reported the efficacy and safety of ductal lavage as a novel treatment. This presentation presents the results of a multicenter, open-label,
APA, Harvard, Vancouver, ISO, and other styles

Dissertations / Theses on the topic "Min jian hu zhu hui"

1

Lu, Haohan. "Cong "Shang ye dian tai ming zui feng mi" ji "Ling hui shang shi chu jiao" shi jian, kan kuang jia jing zheng yu min cui zhu yi /." click here to view the abstract and table of contents, 2005. http://net3.hkbu.edu.hk/~libres/cgi-bin/thesisab.pl?pdf=b19816571a.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Min jian hu zhu hui"

1

author, Wang Shouyan, ed. Jin qian de ao man yu she hui de pian jian: Dang dai xiang cun she hui jian she yu she qu hu zhu yan jiu = Pride of money and prejudice of society. She hui ke xue wen xian chu ban she, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

author, He Jiquan, ed. Min zu wen hua bao hu yu chuan cheng de shi jian zong jie yu li lun tan suo: Yi Zhongguo xi nan zhu min zu wei ge an. Zhi shi chan quan chu ban she, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Ronghua, Yang, Wang Xianjun, Zhang Qicai, and Huang Conghu, eds. Zhongguo min zhu jian guo hui juan. Hebei ren min chu ban she, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Zhang, Yijiong. She hui zhu yi min zhu zheng zhi jian she. Ren min chu ban she dang jian du wu chu ban she, 2015.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Zhongguo min zhu jian guo hui. Zhong yang wei yuan hui. Xuan chuan bu. Zhongguo min zhu jian guo hui shi gao. Min zhu yu jian she chu ban she, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

1938-, Zhang Deming, and Jian cha yuan cai zheng ji jing ji wei yuan hui (China), eds. "Wo guo xiang guan bu men dui yu zhuan li, shang biao, zhu zuo deng zhi hui cai chan quan bao hu ji zhi xing cuo shi ji xiao zhi jian tao" zhuan an diao cha yan jiu bao gao. Jian cha yuan, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zhongguo ming zhu jian guo hui zhong yang wei yuan hui xuan chuan bu., ed. Zhongguo min zhu jian guo hui wu shi nian. Min zhu yu jian she chu ban she, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

1955-, Zhang Boshu, and Wang Shujun, eds. Jiang ju, "po ju" yu Zhongguo min zhu zhuan xing: Hu Zhao jing shen yu xian zheng zhuan xing xue shu yan tao hui lun wen ji yao ji xian chang bian lun shi lu. Chen zhong shu ju, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

"Min jian Ji'an Shi wei hui zhi" bian zuan wei yuan hui. Min jian Ji'an Shi wei hui zhi, 1956-2006. "Min jian Ji'an Shi wei hui zhi" bian zuan wei yuan hui], 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Cui, Haifei. Yi qian ling yi ye: Cai hui zhu yin ban. Er shi yi shi ji chu ban she, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Conference papers on the topic "Min jian hu zhu hui"

1

Xiaozhi Wang and Neil Pegg, ISSC 2022 Editors. "Proceedings of the 21st International Ship and Offshore Structures Congress VOLUME 3 Discussions." In 21st International Ship and Offshore Structures Congress Volume 3 Discussions. SNAME, 2022. http://dx.doi.org/10.5957/issc-2022-discussion-vol-3.

Full text
Abstract:
Committee I.1: Environment Alexander Babanin (Chair); Mariana Bernardino; Franz von Bock und Polach; Ricardo Campos,; Jun Ding; Sanne van Essen; Tomaso Gaggero; Maryam Haroutunian; Vanessa Katsardi; Alexander Nilva; Arttu Polojarvi; Erik Vanem; Jungyong Wang; Huidong Zhang; Tingyao Zhu Floor Discussers: Florian Sprenger; Carlos Guedes Soares; Henk den Besten Committee I.2: Loads Ole Andreas Hermundstad (Chair); Shuhong Chai; Guillaume de Hauteclocque; Sheng Dong; Chih-Chung Fang; Thomas B. Johannessen; Celso Morooka; Masayoshi Oka; Jasna Prpić-Oršić; Alessandro Sacchet; Mahmud Sazidy; Bahadir
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!